MMJ BioPharma is taking its fight for FDA approved cannabis medicine directly to DEA Administrator Terry Cole, as President Trump signals openness to marijuana's medical benefits. After seven years of delays, MMJ is ready to launch clinical trials for Huntington's disease and Multiple Sclerosis- if the DEA finally issues its long overdue API Bulk manufacturing registration.
Read More
Genie Healthcare Expands Leadership in Clinical Workforce Solutions with Strategic Investment in Vizzhy's Healthcare IT Platform
Read More
Auctiva has unveiled major platform upgrades aimed at helping eBay sellers grow their businesses, backed by fresh investment under new ownership. The updates include advanced automation, deeper eBay integration, and AI-powered SEO and listing tools to streamline selling. New support for eBay's Negotiation API enables sellers to send personalized offers to interested buyers, boosting conversions and reducing excess inventory. These innovations will be showcased at the 2025 eBay Open, marking the start of a new era of growth and seller-focus.
Read MoreMipletamig's 85% frontline AML remission rate and favorable safety profile drive APVO's differentiated CD3 portfolio expansion with APVO455, a Nectin-4 x CD3 bispecific for multiple solid tumor types
CD3 bispecific portfolio now includes three candidates - mipletamig (AML), APVO442 (prostate cancer), and newly added APVO455 - advancing a targeted, tumor-specific strategy uniquely engineered for safety, tumor specificity and clinical impact
Mipletamig, continues to outperform benchmarks, trial enrollment continues
$15.9 million raised in 2Q25, extending cash runway into late 4Q25
Read More
As padel grows in popularity, the wellness event "Strong Body, Strong Game" explores how core-focused therapies and aesthetic techniques contribute to better play, faster recovery, and aging well.
Read More